Finzati - Logo
BGLC logo

BioNexus Gene Lab Corp.

BGLC • Industrial - Distribution
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.80M
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Manageable debt level · 0.02Healthy liquidity · 10.46Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:21 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$3.80M
52W Range1.07 - 6.10
Beta2.19
Gross Margin14.62%
Oper. Margin-42.54%
Profit Margin-40.20%
Debt/Eq0.02
Current Ratio10.46
Quick Ratio9.16
Volume2.06K

Investment DNA

How strong this company looks for long-term investors

53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 10.46Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/8/2021
Industry: Industrial - Distribution
P/B i: 0.85
Debt / Equity i: 0.02
Operating Margin: -42.54%
Net Margin: -40.20%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 10.46
Quick Ratio: 9.16
Status: Good

Insider Transactions

Recent executive and insider activity

Low Jook Yuen
Transaction: 08/13/2026
BUY
Change
+16,129
Price
$1.55
Filing
08/14/2026
Type
BUY
Chong Set Fui
Transaction: 08/13/2026
BUY
Change
+96,774
Price
$1.55
Filing
08/14/2026
Type
BUY
Bin Abdul Hamid Muhammad Azrul
Transaction: 08/13/2026
BUY
Change
+32,258
Price
$1.55
Filing
08/14/2026
Type
BUY